Refine by
Cardiac Rhythm Management Articles & Analysis
27 news found
The OCEANIC-AF (atrial fibrillation) study with asundexian is part of the Phase III OCEANIC clinical trial program enrolling more than 27,000 patients in over 40 countries Asundexian is being evaluated as a potential improved treatment option in stroke prevention and could be part of an entirely new class of treatment options in thrombosis management that aims to uncouple ...
ByBayer AG
” I am thrilled to be joining Medicalgorithmics, a software company with a long history of providing best in class cardiac rhythm analysis. I look forward to building the North American market and expanding the reach of Medicalgorithmics’ ...
The XARENO study results provide important evidence that can help physicians in the management of patients with atrial fibrillation and chronic kidney disease and help reduce patients’ risk of progressing to kidney failure,” said Reinhold Kreutz, Professor of Clinical Pharmacology, Charité - Universitätsmedizin Berlin, Germany. ...
ByBayer AG
The OCEANIC program will start with two Phase III studies investigating the efficacy and safety of asundexian in prevention of stroke events in patients with atrial fibrillation as well as patients with a non-cardioembolic ischemic stroke or high-risk transient ischemic attack involving up to 30,000 patients Bayer drives the development of its FXIa inhibitor, with the goal of offering a ...
ByBayer AG
Today, MicroPort® is focused in covering ten major areas, including Cardiovascular Intervention & Structural Heart Diseases, Electrophysiology & Cardiac Rhythm Management, Orthopedics & Soft Tissue Repair, Endovascular & Peripheral Vascular Diseases, Neurovascular Intervention & Neurosciences, Life Sciences (Endocrine ...
ByRobocath
Procyrion, Inc., a medical device company developing a catheter-deployed micropump for the management of chronic heart failure, has named Eric S. Fain, MD as President and Chief Executive Officer effective immediately. ...
Today, MicroPort is focused in covering ten major areas, including cardiovascular intervention & structural heart diseases, electrophysiology & cardiac rhythm management, orthopedics & soft tissue repair, endovascular & peripheral vascular diseases, neurovascular intervention & neurosciences, life sciences (endocrine ...
ByRobocath
WiSE technology enables cardiac pacing of the left ventricle with a novel cardiac implant that is roughly the size of a large grain of rice. ...
Dr Steinhaus was formerly Vice President and General Manager of the Heart Failure Business for the Cardiac Rhythm and Heart Failure Division at Medtronic Plc (NYSE:MDT). Dr Steinhaus has extensive clinical and business experience in cardiac rhythm management, including performing numerous ...
BackBeat CNT has the potential to be integrated into any dual-chamber pacemaker system, making this therapy highly suitable for Orchestra BioMed’s risk-reward sharing strategy of pursuing commercialization through a strategic partnership with a leading cardiac rhythm management company. About Orchestra BioMed Orchestra BioMed is a ...
About EBR Systems Silicon Valley-based EBR Systems is dedicated to superior treatment of cardiac rhythm disease by providing more physiologically effective stimulation through wireless cardiac pacing. The company’s patented proprietary Wireless Stimulation Endocardially (WiSE) technology was developed to eliminate the need for ...
A recent study confirms the high accuracy of the Uscom BP+ central blood pressure monitor for detection of the dangerous cardiac rhythm abnormality Atrial Fibrillation (AF) in a primary care setting. This result confirms that BP+ suprasystolic oscillometry is 94% effective for detection of AF in home care environments and may be used as a screening investigation. ...
Paul Cornelison and Michael Webb have previously held senior management positions at top medtech companies and successful start-ups. ...
ByCorWave
About EBR Systems Silicon Valley-based EBR Systems is dedicated to superior treatment of cardiac rhythm disease by providing more physiologically effective stimulation through wireless cardiac pacing. The company’s patented proprietary Wireless Stimulation Endocardially (WiSE) technology was developed to eliminate the need for ...
Graduated from University of Applied Sciences in Ulm in Mechanical Engineering and holding an MBA in Corporate Management, Ivo Simundic is a seasoned sales director with over 20 years of experience in the medical device industry. Ivo started his career within the healthcare sector in 1999 at Medtronic as a Sales Engineer in Cardiac Rhythm ...
ByCarmat
Boyle also spent 17 years with Medtronic in a variety of sales roles in Canada and the U.S., including Regional Vice President of Sales for the Cardiac Rhythm Management business. “We’re thrilled to welcome Amy to the executive team. ...
About EBR Systems Silicon Valley-based EBR Systems is dedicated to superior treatment of cardiac rhythm disease by providing more physiologically effective stimulation through wireless cardiac pacing. The company’s patented proprietary Wireless Stimulation Endocardially (WiSE) technology was developed to eliminate the need for ...
“With the extensive clinical data and commercial experience of Cardiac Dimensions, I’m very excited about what the future holds for the company and the benefits the technology can bring to ...
Bryan is an important addition to our senior management team, and I am excited to welcome him to the Inspire family.” Most recently, Mr. ...
Per Professor Bardy, such individuals, as well as those with known underlying heart disease should consider cardiac monitoring. Those over the age of 60 regardless of health status would probably benefit from a heart rhythm evaluation just as they do other periodic checks of their health, like blood pressure, cholesterol, mammography, glucose, etc. ...